1. Home
  2. AADI vs ENZ Comparison

AADI vs ENZ Comparison

Compare AADI & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • ENZ
  • Stock Information
  • Founded
  • AADI 2011
  • ENZ 1976
  • Country
  • AADI United States
  • ENZ United States
  • Employees
  • AADI N/A
  • ENZ 136
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • ENZ Medical Specialities
  • Sector
  • AADI Health Care
  • ENZ Health Care
  • Exchange
  • AADI Nasdaq
  • ENZ Nasdaq
  • Market Cap
  • AADI 59.4M
  • ENZ 37.9M
  • IPO Year
  • AADI N/A
  • ENZ N/A
  • Fundamental
  • Price
  • AADI $2.34
  • ENZ $0.72
  • Analyst Decision
  • AADI Hold
  • ENZ
  • Analyst Count
  • AADI 3
  • ENZ 0
  • Target Price
  • AADI $1.75
  • ENZ N/A
  • AVG Volume (30 Days)
  • AADI 109.6K
  • ENZ 198.0K
  • Earning Date
  • AADI 11-06-2024
  • ENZ 12-16-2024
  • Dividend Yield
  • AADI N/A
  • ENZ 14.27%
  • EPS Growth
  • AADI N/A
  • ENZ N/A
  • EPS
  • AADI N/A
  • ENZ N/A
  • Revenue
  • AADI $25,070,000.00
  • ENZ $30,314,000.00
  • Revenue This Year
  • AADI $9.39
  • ENZ N/A
  • Revenue Next Year
  • AADI $6.15
  • ENZ N/A
  • P/E Ratio
  • AADI N/A
  • ENZ N/A
  • Revenue Growth
  • AADI 7.80
  • ENZ 2.72
  • 52 Week Low
  • AADI $1.21
  • ENZ $0.68
  • 52 Week High
  • AADI $2.63
  • ENZ $1.50
  • Technical
  • Relative Strength Index (RSI)
  • AADI 58.75
  • ENZ 16.88
  • Support Level
  • AADI $2.25
  • ENZ $0.68
  • Resistance Level
  • AADI $2.45
  • ENZ $1.05
  • Average True Range (ATR)
  • AADI 0.11
  • ENZ 0.06
  • MACD
  • AADI -0.01
  • ENZ -0.03
  • Stochastic Oscillator
  • AADI 39.89
  • ENZ 7.00

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Share on Social Networks: